A recent study reported that BAP18 is upregulated in non–small cell lung carcinoma (NSCLC), particularly in advanced-stage tumors, and promotes tumor cell proliferation by enhancing the transcription of cell cycle–related genes, such as CCND1 (cyclin D1) and CCND2 (30). This evidence concerns the gene CCND2 and non-small cell lung carcinoma.